je.st

Home › threeyear

Tag: threeyear

Apple's smartphone market share drops to three-year low

2013-07-26 14:03:34| InfoWorld: Top News

Apple's share of the smartphone market dropped in the second quarter to its lowest level in three years, research firm Strategy Analytics said. The share of the iPhone slipped to 13.6 percent in the quarter from 16.6 percent in the same quarter last year. The largest vendor Samsung Electronics, however, saw its share soar to over 33 percent from over 31 percent in the same period. Samsung shipped over two times the number of smartphones Apple did in the quarter, Strategy Analytics said.

Tags: low share market drops

Minnesota Diversified Industries (MDI) Awarded Three-Year CARF Accreditation

2013-06-27 06:00:00| Industrial Newsroom - All News for Today

MDI has been accredited for period of 3 years for its Affirmative Business Enterprise, Community Employment Services, Employee Development, and Employment Planning Services. Accreditation decision represents highest level of accreditation that can be awarded to an organization and shows organization’s substantial conformance to CARF standards. MDI has demonstrated to team of surveyors that its programs and services are of the highest quality, measurable, and accountable. This story is related to the following:Trade Associations

Tags: industries minnesota awarded accreditation

St. Louis Skilled Electricians Have New Three-Year Agreement

2013-06-24 23:38:00| Electrical Construction & Maintenance

Much-anticipated three-year contract has been reached for skilled electricians in St. Louis. read more

Tags: agreement louis skilled electricians

FDA Approves U.S. Product Labeling Update For Sprycel (Dasatinib) To Include Three-Year First-Line And Five-Year Second-Line Efficacy And Safety Data In Chronic Myeloid Leukemia In Chronic Phase

2013-06-20 16:10:00| dairynetwork News Articles

Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved an update to the Sprycel (dasatinib) product labeling. The labeling now includes three-year efficacy and safety data in patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP) and five-year data in CP Ph+ CML patients who are resistant or intolerant to Gleevec®1 (imatinib mesylate)

Tags: in data include product